FDA Concerned About Testicular Toxicity in Drugs

Drug Industry Daily
A A
Companies developing therapies that may have an adverse effect on the testes should conduct clinical trials to pin down the toxicity and whether it is reversible, the FDA says.

To View This Article:

Login

Subscribe To Drug Industry Daily